ResMed acquires insomnia digital well being answer somnio

San Diego-based medical gadget firm ResMed has introduced the acquisition of mementor, a client software program developer that provides a digital answer for insomnia.
 
The monetary phrases of the transaction weren’t disclosed.

The acquisition of Leipzig, Germany-based mementor lays the inspiration for ResMed to construct its digital sleep medication portfolio in Germany, the corporate mentioned. The deal was accomplished on Aug. 1.

Mementor can be built-in into ResMed in Germany as a separate enterprise phase and can function a platform for additional developments within the area of digital well being. By means of the acquisition, mementor can leverage ResMed Germany’s broader community to extend adoption of its digital well being software, somnio.
 
The enterprise phase can be co-led by mementor co-founder and CEO Dr. Noah Lorenz and Katherina Jekerle, who was beforehand ResMed Germany’s senior advertising and marketing director and a member of the German management workforce.

WHY THIS MATTERS

Mementor developed the digital well being software somnio, which focuses on enhancing sleep in sufferers with recognized insomnia. Somnio fills a care hole by offering an alternative choice to prevailing drug remedy.

ResMed mentioned somnio enhances its efforts to extend consciousness of insomnia and sleep apnea and provides entry to efficient residence therapies. 

Somnio is out there in Germany by way of “app on prescription.”

Somnio is Germany’s first and solely completely accredited digital well being software within the area of sleep medication, based on ResMed. This makes it eligible for reimbursement in Germany.

The medical effectiveness of somnio has been demonstrated in two randomized managed trials, exhibiting a sustained enchancment in customers’ sleep after two and 12 months, based on ResMed.

THE LARGER TREND

Based in Switzerland in 2014 by Dr. Noah Lorenz, Alexander Rötger, Jan Kühni and Daniel Rotzetter, mementor developed and owns the digital insomnia remedy answer somnio.

It’s Germany’s first and solely completely accredited Digital Well being Utility (DiGA) within the area of sleep medication and can also be compliant with the European Union’s knowledge safety necessities below the Normal Knowledge Safety Regulation.

In Germany, roughly 1 in 10 individuals are affected by clinically related insomnia, in addition to almost 3 in 10 individuals who have sleep apnea. 

At the moment solely a small proportion of these affected obtain the cognitive behavioral remedy for insomnia (CBT-I) advisable in Germany’s S3 guideline, based on ResMed. 

ResMed gives out-of-hospital software program packages to help individuals with sleep apnea, COPD and different power illnesses. 

In June, ResMed signed a definitive settlement to amass Medifox Dan, a German out-of-hospital software program firm, from software program investor Hg for $1 billion (€950 million).

ON THE RECORD

Katrin Pucknat, president at ResMed Germany, mentioned, “The founders have recognized a big and uncared for space of wholesome sleep with a chance to assist hundreds of thousands of individuals remedy their power sleep difficulty with an easy-to-use digital at-home answer. We stay up for working with the workforce at mementor to assist much more individuals in Germany obtain good, wholesome sleep.”
 

Twitter: @SusanJMorse
E mail the author: [email protected]